secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lineage Cell Therapeutics, Inc. (LCTX)
CIK:        0000876343
Form:       8-K
Filed at:   2023-06-21T23:59:59+00:00
Accession:  0001493152-23-022030
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Lineage Cell Therapeutics sets 2023 annual meeting for September 6; proposal deadline July 14
--------------------------------------------------------------------------------

- Annual Meeting scheduled for September 6, 2023.
- Shareholder proposals and nominations due by July 14, 2023.
- Rule 14a-8 proposals for proxy statement also due July 14.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/876343/000149315223022030/0001493152-23-022030-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/876343/000149315223022030/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-022030

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer